mitomycin C
Compare the Safety and Efficacy of Sub-conjunctival application of Sponges Soaked in Mitomycin-C (MMC:0.02%) to that of Direct Injection of Mitomycin-C (MMC:0.02%) into the Sub-conjunctival Space in Trabeculectomy or Phacotrabeculectomy: A Randomized Controlled Trial
... Glaucoma is an ocular condition with multi-factorial etiology. The condition is most often bilateral. Progressive optic nerve damage resulting in blindness is the hallmark of untreated glaucoma. Intraocular pressure ...
153
VEGF111b, a C terminal splice variant of VEGF A and induced by mitomycin C, inhibits ovarian cancer growth
... as mitomycin C ...of mitomycin C inducing double- strand breaks, which is similar to VEGF111 ...mycin C triggers double-strand breaks which is the dependent of VEGF111 ...
10
Single step assembly of polymer lipid hybrid nanoparticles for mitomycin C delivery
... Mitomycin C is one of the most effective chemotherapeutic agents for a wide spectrum of cancers, but its clinical use is still hindered by the mitomycin C (MMC) delivery ...
14
Effects of Chinese herbal medicine in combination with mitomycin C on gastric cancer cells
... Chinese herbal medicine (CHM) is frequently used by cancer patients in Chinese community. It remains largely unknown about the interaction between CHM and chemotherapeutic agents. Herein, we evaluated 3 commonly used CHM ...
5
Low Releasing Mitomycin C Molecule Encapsulated with Chitosan Nanoparticles for Intravesical Installation
... of Mitomycin-C encapsulated with chitosan nanoparticles synthesis using ionic gelation technique for intravesical controlled drug delivery ...of Mitomycin-C with three different initial ...
17
The histopathological effects of intracavernosal mitomycin C injection in a rat Peyronie's disease model
... staining can be used for evaluating the fibrosis level. Mitomycin-C (MMC), a chemotherapeutic agent, shows antitumoural and antifibrotic activity. Occleston et al report- ed that MMC reduced fibrosis on ...
5
Subconjunctival bevacizumab to augment trabeculectomy with mitomycin C in the management of failed glaucoma surgery
... All procedures were performed under local peribulbar anes- thesia. Subconjunctival saline injection was first done at the site of the proposed flap (away from the previous failed bleb) to facilitate dissection of the ...
11
Consecutive bilateral decompression retinopathy after mitomycin C trabeculectomy: a case report
... therapeutic compliance, who chose surgical treatment based on her inability to consistently use ocular drops. Our patient underwent a trabeculectomy with mitomycin C in both eyes, with surgeries taking ...
6
Corneal lamellar grafting to repair late complications of mitomycin C trabeculectomy
... with mitomycin C for Japanese glaucoma ...M. Mitomycin C augmented glaucoma sur- gery: Evolution of filtering bleb avascularity, transconjunctival oozing, and ...
6
Intravitreal bevacizumab with or without mitomycin C trabeculectomy in the treatment of neovascular glaucoma
... Results: All cases showed complete regression of iris neovessels at 2 months after injection; recurrence of iris neovessels was observed in 4 cases (20%) at 4 months and in 14 cases (70%) at 8 months follow-up. The mean ...
5
Study on the role of mitomycin C in the Management of ocular surface squamous neoplasia
... 0.04% Mitomycin C eye drops 4 times per day was given approximately for 2 weeks after surgical excision, each cycle lasting for 1 week with off period of 1 week in ...
127
Efficacy and safety of preoperative 5 fluorouracil, cisplatin, and mitomycin C in combination with radiotherapy in patients with resectable and borderline resectable pancreatic cancer: a long term follow up study
... The NACRT regimen consisted of a combination of 4 cycles of chemotherapy (continuous administration of 5-FU; cisplatin on day 5, 12, 19, and 26; mitomycin C on day 6, 13, 20, and 27; and heparin infusion) ...
8
Treatment Of Ocular Surface Squamous Neoplasia (OSSN) With Surgical Excision & Adjunctive Topical Mitomycin C TherapyShweta Walia, Kumar Saurabh Srivastava, V. Bhaisare, Vaibhav Sharma, Dinesh Agarwal, Priyanka Mandraha
... Despite the effort to excise the tumor with a wide healthy rim, only 2cases (28%) had marginal clearance and the rest had residual dysplastic edges, suggestive of multifocal origin of OSSN or macroscopically invisible ...
5
Inhibitory and Apoptotic Effects of Mannan-Mitomycin C Conjugate Against Transitional Cell Carcinoma and Normal Mouse Fibroblasts
... of mitomycin C at 400 μg/ml, 2 mL of mitomycin C at 25 μg/ml, 2 mL of mannan at 1250 μg/ml, and a well for each cell line with no treatment as a negative ...
9
Comparing the cytotoxicity of taurolidine, mitomycin C, and oxaliplatin on the proliferation of in vitro colon carcinoma cells following pressurized intra peritoneal aerosol chemotherapy (PIPAC)
... Intraperitoneal chemotherapy (IPC) has gained increasing acceptance in the past 20 years and has since been fre- quently used and extensively studied. Limitations concern- ing drug delivery to solid cancer formations ...
7
Treatment of multiple-level tracheobronchial stenosis secondary to endobronchial tuberculosis using bronchoscopic balloon dilatation with topical mitomycin-C
... of mitomycin-C as an adjunct therapy to bronchoscopic procedures in our case was influenced by reports of successful treatment in patients with tracheal stenosis secondary to intubation [14, ...of ...
6
<p>Management of Recurrent Pterygium with Severe Symblepharon Using Mitomycin C, Double Amniotic Membrane Transplantation, Cryopreserved Limbal Allograft, and a Conjunctival Flap</p>
... Figure 3 Preoperative and postoperative appearances. Upper column, Case 1 and lower column, Case 2. (A) Case 1. Before excision of a recurrent pterygium combined with application of mitomycin C, double ...
9
Single early instillation of mitomycin C and urinary alkalinization in low-risk non-muscle-invasive bladder cancer: a preliminary study
... Background: The purpose of this study was to determine the effectiveness of a single early instillation of mitomycin C (MMC) after transurethral resection of bladder tumor (TURBT) tog[r] ...
6
A comparative study in the use of topical mitomycin-C versus nasolacrimal stent in endoscopic dacryocystorhinostomy for chronic dacryocystitis
... Patients in Group B underwent bicanalicular siliastic stenting. Stent was passed through upper and lower lacrimal punctum into the sac (Figure 4 and 5). The parts of the stent with in the eye were kept a little loose so ...
9
Efficacy of mitomycin c in endoscopic dacryocystorhinostomy
... Intraoperative mitomycin C prevents narrowing of ostium. Topical mitomycin C is safer with no local adverse ...adjuvant mitomycin C enhances the success rate of surgery with less ...
5